U Hedner Selected Research

U Hedner Research Topics

16	Hemorrhage 11/2013 - 01/2000
15	Hemophilia A (Haemophilia) 11/2012 - 01/2000
4	Hemophilia B (Haemophilia B) 11/2013 - 09/2001
4	Wounds and Injuries (Trauma) 11/2013 - 04/2000
3	Thrombasthenia (Glanzmann Thrombasthenia) 01/2008 - 04/2000
3	Liver Diseases (Liver Disease) 03/2002 - 04/2000
3	Thrombosis (Thrombus) 05/2001 - 01/2000
2	Body Weight (Weight, Body) 11/2012 - 09/2011
2	Joint Diseases (Joint Disease) 11/2008 - 09/2001
2	Thrombocytopenia (Thrombopenia) 10/2001 - 07/2001
1	Acute Pain 11/2012
1	Vascular Remodeling 08/2007
1	Necrosis 12/2005
1	Vitamin K Deficiency 03/2002
1	Contracture 09/2001
1	Neointima 05/2001
1	Vascular System Injuries 05/2001
1	Hypothermia 04/2001
1	Reperfusion Injury 12/2000
1	Sepsis (Septicemia) 12/2000
1	Venous Thromboembolism 06/2000
1	Vascular Diseases (Vascular Disease) 04/2000
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2000
1	Epistaxis (Nosebleed) 04/2000
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2000
1	Multiple Trauma (Multiple Injuries) 01/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2000

21	recombinant FVIIa (rFVIIa)FDA Link 09/2011 - 01/2000
11	Factor VIIa (Activated Factor VII)IBA 11/2012 - 04/2000
5	Thrombin FDA Link 01/2011 - 07/2001
5	Factor VII (Proconvertin)IBA 01/2008 - 04/2000
4	Factor VIII (Coagulation Factor VIII)IBA 11/2009 - 01/2000
4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2009 - 01/2000
4	Heparin (Liquaemin)FDA LinkGeneric 05/2008 - 01/2000
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2008 - 01/2000
3	FibrinIBA 12/2005 - 06/2003
3	Warfarin (Coumadin)FDA LinkGeneric 06/2000 - 04/2000
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2011 - 04/2001
2	NN1731IBA 11/2009 - 05/2008
2	Tinzaparin (Innohep)FDA Link 05/2008 - 01/2000
2	Hemostatics (Antihemorrhagics)IBA 08/2007 - 06/2003
2	AnticoagulantsIBA 04/2003 - 03/2002
2	Thromboplastin (Tissue Factor)IBA 05/2001 - 04/2000
2	Vitamin K FDA Link 06/2000 - 04/2000
1	IronIBA 11/2013
1	Endothelial Protein C ReceptorIBA 11/2012
1	AntithrombinsIBA 02/2011
1	Pharmaceutical PreparationsIBA 05/2009
1	prothrombin complex concentrates (PPSB)IBA 11/2008
1	A-factor (Streptomyces)IBA 05/2008
1	AntibodiesIBA 01/2008
1	Platelet Membrane GlycoproteinsIBA 01/2008
1	Platelet Membrane Glycoprotein IIbIBA 01/2008
1	Fibrinogen (Factor I)FDA Link 01/2008
1	Protamines (Protamine Sulfate)FDA Link 04/2003
1	AntidotesIBA 04/2003
1	Dacarbazine (DIC)FDA LinkGeneric 03/2002
1	Messenger RNA (mRNA)IBA 05/2001
1	LipopolysaccharidesIBA 12/2000
1	factor VII clotting antigenIBA 04/2000
1	Prothrombin (Factor II)IBA 04/2000

5	Therapeutics 11/2013 - 01/2000
3	Intravenous Administration 02/2011 - 04/2001
1	Time-to-Treatment 05/2009
1	Injections 05/2009
1	Length of Stay 11/2008
1	Punctures 04/2003
1	Vascular Surgical Procedures 05/2001
1	Operative Surgical Procedures 04/2000
1	Orthopedic Procedures 01/2000